MMM
3M CO
Healthcare • CIK 0000066740
Loading...
Market Cap
$83.50B
P/E (TTM)
28.5x
Rev Growth (TTM)
+2.3%
Net Margin (TTM)
11.9%
FCF Yield (TTM)
4.7%
FCF Margin (TTM)
15.8%
Filings
Primary-source SEC disclosures, read end-to-end — every figure traceable to its filing.
10-Q2026 Q22026-07-21source
8-KEarnings2026-07-21source
8-KJun 20262026-06-08source
8-KMay 20262026-05-13source
8-KMay 20262026-05-06source
What your agent reads
Investor Relations
Company-published material — management’s own words, not SEC-audited. Each source below is labeled so your agent knows what to verify.
Company-published, not SEC-audited
Earnings
Q2 2026
27 days ago
8-K releaseRevenue
$6.50B
+2.4%
Net Income
$933.00M
+29.1%
EPS
N/A
—
Most recent quarterly earnings snapshot
Cash Flow Health
Free Cash Flow5/8 positive
TTM$4.0B
Q2 '26
$763M+119%
Q1 '26
$349M-74%
FCF Margin
TTM15.8%
Q2 '2611.7%+103%
Sector: 0.0%Top 10%
OCF Margin19.5%
OCF/NI1.63x
CapEx Coverage5.4x
FCF Yield4.7%
FCF Growth (2Y)-4%
Cash Conversion Cycle
78 days
DSO: 54+DIO: 91−DPO: 67
Cash flow trends & capital efficiency
Capital Allocation
Total Shareholder YieldTTM
TTM6.6%
Div Yield1.9%
+Buyback (TTM)4.7%
Dividend & Payout Metrics
Dividend Yield (TTM)1.9%
FCF Payout Ratio39.0%
Free Cash Flow (TTM)$4.0B
Stock Repurchases (TTM)$4.0B
Capital Return / FCF140.7%
Est. Dividends Paid (TTM)$1.6B
Shows how management rewards shareholders
Valuation Metrics
Price-to-EarningsTTM
28.5x
Volatile
8Q: 24.4x+1184%
Multiple expansion without fundamental improvement
Valuation Lenses
Earnings
28.5x
vs – sector
Cash Flow
22.5x
EV/FCF vs –
Growth-Adj
–PEG
N/A
Quality-Adj
1.7P/E per %ROIC
ROIC: 16.9%
Shareholder Returns
Dividend
1.9%
Buyback
4.7%
Total Yield
6.6%
Market Cap$83.50B
EV$93.10B
Multi-angle valuation analysis with sector context
Margins & Efficiency
ROIC 75th pctile
Profitability Cascade
Gross
39.4%
Operating
18.4%
Top 25% in sector
Net
11.9%
Margins Unknown
Return on Invested CapitalTTM
16.9%
Stable
-0.0% YoY-3.8%
P25MedianP75
75th pctl (med: -0.0%)
DuPont BreakdownROIC = Margin × Turn × (1+D/E)
NOPAT Margin
14.1%
8Q: 16.5%
Asset Turnover
0.68x
8Q: 0.65x
Leverage (1+D/E)
5.25x
D/E: 4.25x
DuPont: 50.8% ≈ 16.9% ROIC
Asset & CapEx Efficiency
Fixed Asset Turn
3.54x
8Q:3.43x
+37.8%
Invested Cap Turn
1.19x
8Q:1.18x
+6.5%
CapEx Intensity
4.3%
8Q:4.5%
CapEx/Depreciation
0.66x
FCF vs Net Margin Gap+3.9 pts
Margin trends, ROIC, and capital efficiency
Balance Sheet & Solvency
D/E 4.25x
Net Debt / EBITDA
–Net Debt: $9.60B
Interest Coverage
–
Leverage Metrics
Debt-to-Equity
4.25x
Balance sheet risk & solvency analysis
Related Research
2 related posts